Document is current
Any future updates will be listed below
-
Authors
Wang, Shuai http://orcid.org/0000-0002-5432-4970
Han, Lei
Han, Jungsoo
Li, Peng
Ding, Qing
Zhang, Qing-Jun
Liu, Zhi-Ping
Chen, Chuo
Yu, Yonghao http://orcid.org/0000-0001-8414-4666
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM122932, GM122932, GM122932)
Welch Foundation (I-1800, I-1800)
- License Information
-
More Information
Article History
Received: 2 November 2018
Accepted: 5 September 2019
First Online: 28 October 2019
Competing interests
: Y.Y. receives research support from Pfizer. A provisional patent application on the PARP degraders and technologies described herein has been filed by Y.Y., C.C., S. W. and L. H.
